Affiliation:
1. Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health
2. Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA
Abstract
Background:
Mainland China experienced a major surge in SARS-CoV-2 infections in December 2022–January 2023, but its impact on mortality was unclear given the underreporting of coronavirus disease 2019 deaths.
Methods:
Using obituary data from the Chinese Academy of Engineering (CAE), we estimated the excess death rate among senior CAE members by taking the difference between the observed rate of all-cause death in December 2022–January 2023 and the expected rate for the same months in 2017–2022, by age groups. We used this to extrapolate an estimate of the number of excess deaths in December 2022–January 2023 among urban dwellers in Mainland China.
Results:
In December 2022–January 2023, we estimated excess death rates of 0.94 per 100 persons (95% confidence interval [CI] = −0.54, 3.16) in CAE members aged 80–84 years, 3.95 (95% CI = 0.50, 7.84) in 85–89 years, 10.35 (95% CI = 3.59, 17.71) in 90–94 years, and 16.88 (95% CI = 0.00, 34.62) in 95 years and older. Using our baseline assumptions, this extrapolated to 917,000 (95% CI = 425,000, 1.45 million) excess deaths among urban dwellers in Mainland China, much higher than the 81,000 in-hospital deaths officially reported from 9 December 2022 to 30 January 2023.
Conclusions:
As in many jurisdictions, we estimate that the coronavirus disease 2019 pandemic had a much wider impact on mortality than what was officially documented in Mainland China.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献